Click to view this email in a browser

Forward this message to a colleague

CAMA Winter Newsletter
CAMA Newsletter | Winter 2015

  CAMA Winter Newsletter


Special Message From CAMA Co-Chairs

It’s finally here—2015—a date that is synonymous with the close of the Millennium Development Goals (MDGs) and the launch of the Sustainable Development Goals (SDGs). While the New Year brings an enthusiasm for fresh starts, it also signals the acceleration of work still to be completed in the fight against malaria. Within CAMA, we are indebted to you for your continued support of the Alliance both in dollars and in-kind resources.

In 2014, we carried out several activities and convenings, built relationships with new and valuable stakeholders, welcomed a new addition to the team and facilitated the start of our 2015 program planning process. All of which gives us the confidence to carry out a robust plan, with your partnership, in this very important milestone year. A snapshot of our key successes include:

  • We further strengthened our ties with the United Nations Special Envoy for Financing the Health Millennium Development Goals and for Malaria (UNSEO), co-locating with the office in early 2014. This move facilitates deeper interaction with not only the UNSEO but also its broader partner network, including various UN agencies, the Roll Back Malaria Partnership and the African Leaders Malaria Alliance.
  • Our annual World Malaria Day 2014 Webinar drew a record number of participants who joined to hear Leith Greenslade (MDG Health Alliance), Suprotik Basu (UNSEO) and Elaine Roman (Jhpeigo) share their insights on the critical need to integrate malaria prevention efforts with maternal and child health interventions.
  • We warmly welcomed new CAMA members Access Bank, ExxonMobil, Nigerian Breweries and Wapic Insurance Plc. These leading companies have demonstrated leadership in the fight against malaria at a global and local level; we look forward to supporting their efforts in 2015 via the CAMA platform.
  • Our in-country efforts focused heavily on Nigeria, a key country for MDG achievement. In July 2014, we convened the Nigeria Private Sector Technical Forum on malaria and maternal and child health in Abuja. Co-hosted by the Nigerian Federal Ministry of Health’s National Malaria Elimination Program (NMEP), Access Bank and other key partners, the event brought together over 120 participants representing over 20 companies and more than 30 government, civil society and academic institutions.
  • As a result of the July Forum, we created a dedicated Nigeria workstream. In 2015, we will continue our relationship with the NMEP, and with their guidance, further engage the country’s private sector in malaria efforts. Former CAMA Manager Ochuko Keyamo, now based in Nigeria, will assist with the implementation of this workstream.
  • We welcomed Mr. Isaiah Owolabi as our Program Manager in New York focusing on CAMA’s global strategy and communications. Read more about Isaiah later in this newsletter.
  • We launched a CAMA-specific Twitter handle. Follow us on @CAMANews to stay up-to-date on business and malaria.
  • We wrapped up the year at the American Society of Tropical Medicine and Hygiene Meeting (ASTMH) with a private dinner for CAMA members and key partners. This was our first time at ASTMH and thanks to your engagement we initiated a new level of dialogue that will boost deeper connections and partnerships in 2015. We were also inspired by Bill Gates’ keynote. If you missed his speech, click here to watch.

We are proud of the progress we collectively made in 2014. With your continued partnership, guidance and support we look forward to achieving more in the year ahead. As usual, do not hesitate to reach any of us on the CAMA team by emailing with your comments and questions. Together we can achieve a malaria free world!

Here’s wishing you a year filled with continued achievements and successful partnerships.

Ernesto De La Torre, Global Public Health Coordinator, Chevron

Gerhard Hesse, Head of Global Partnering/Vector Control, Bayer S.A.S.

Join Us: Q1 Members’ Teleconference

Tuesday, February 3 | 11:00 EST/4:00 PM UTC

In 2015 CAMA will host a series of quarterly calls to bring together members and key partners to discuss pertinent issues on malaria, share ongoing plans and opportunities for engagement and brainstorm ideas on malaria actions in the transition to the SDGs.

Please RSVP to Dial-in details and agenda will be circulated to confirmed participants.


Highlighted below are opportunities for CAMA members and others to become more engaged in the fight against malaria. Contact us for more information on these and other opportunities.

Call for Corporate Case Studies

CAMADoes your company implement, fund or support a malaria program in Nigeria? Do you partner with a company on an innovative malaria program in Nigeria? If so, CAMA wants to know! In support of the NMEP’s push to gather more information on the private sector’s engagement in malaria, CAMA is facilitating a call for case studies to share knowledge and promote the private sector as an active partner in the malaria fight. Completed case studies will be disseminated across the GBCHealth, NMEP, Roll Back Malaria Partnership and broader malaria networks in 2015.

Click here to download the Case Studies Form or contact Maggie Arbogast at

Help Expand the CAMA Team: Global Health Corps Fellowships Open

The Global Health Corps fellowship program is a unique opportunity for accomplished young professionals to develop the leadership skills and relationships that will prepare them for deepened impact on global health over the course of their careers.

Two Global Health Corps positions are currently available at GBCHealth; the Malaria Program Officer will promote business engagement on malaria, supporting the CAMA team. Applications close Feb. 3rd, 2015.

Global Fund Private Sector Delegation Accepting Board Member Nominations

CAMAThe Private Sector Delegation (PSD) to the Board of the Global Fund is now accepting applications for Board Member and Alternate Board Member positions for the upcoming 2015-2017 term. The PSD Board Member and Alternate will represent the private sector as a voting constituency to the Global Fund’s governance board for a two-year term starting on April 1st, at the close of the Global Fund 33rd Board Meeting. Board Representatives are elected by the PSD Advisory Group, a group of member companies committed to providing ongoing input and guidance on decisions and matters related to the Global Fund. Read more here.

Interested applicants must submit a candidate questionnaire to no later than February 12th.

Support Seasonal Malaria Chemoprevention and Nutrition in Nigeria

An innovative partnership is integrating nutrition provision into the delivery platform of malaria prevention to reduce child mortality during the rainy season.

Undernourishment is a significant underlying factor in the deaths of an estimated 1.5 million children in Africa each year, including about 50 percent of malaria associated deaths. Integrating nutrition programming with Seasonal Malaria Chemoprevention (SMC), campaigns has the potential to provide nutritional fortification to an additional 18.7 million children.

In Kano state, a four-month pilot launched by CHAI, UNICEF and the Government of Nigeria with funding from the Children’s Investment Fund and commodity donations by Nutriset, hopes to generate evidence on the impact of nutrition programs on malaria outcomes, and the operational feasibility of adding such interventions to SMC delivery.

It is anticipated that expanded integrated programs could be funded through leveraging existing and future funding for SMC delivery platforms—ten African countries have already adopted SMC delivery platforms, making the immediate scale-up of shared delivery of SMC and nutrition feasible.

Read more here and contact Jessica Johnston for more information or if you wish to partner.

Isaiah Owolabi Joins GBCHealth as CAMA Program Manager

Isaiah comes to GBCHealth with over six years of experience implementing development initiatives aimed at combating HIV/AIDS, malaria, and environmental degradation and incorporating business models for such interventions, Isaiah is the co-founder of HACEY Health Initiative and of the International Youth Alliance on Family Planning. A testament to his leadership, Isaiah has received countless recognitions for his work including the prestigious Queen Elizabeth Young Leaders Award.

Isaiah can be reached at


Highlights of the 2014 World Malaria Report

The World Malaria Report 2014 reveals that while we continue to make tremendous progress towards a malaria free world, we are still falling short:

CAMAIn 2013, international and domestic funding for malaria control and elimination totaled USD 2.7 billion; although representing a threefold increase since 2005, this is still significantly below the estimated USD 5.1 billion required to achieve global targets for malaria control and elimination. International and domestic funders must prioritize further investments for malaria control.

Africa continues to carry the burden of the disease with 90 percent of deaths still occurring on the continent; Nigeria and DRC remain key epicenters of the disease.

Vector control interventions have increased significantly with over 200 million insecticide treated bednets produced in 2014 and can contribute to further reducing child deaths by the end of 2015. However, more needs to be done to foster new technologies in vector control, ensure quality control and get products approved and to market rapidly.

Resistance continues to play a major challenge to a malaria free world. The detection of P.falciparum resistance to artemisinin threatens to reverse the progress made in countries such as Myanmar, while pyrethroid resistance in Anopheles mosquito vectors in sub-Saharan Africa also poses a threat in a region where ITN intervention is the leading preventative measure.

Download the full report or read the summary of key points.

Fighting Malaria Alongside Ebola

Dr. Fatoumata Nafo-Traore (Executive Director, RBM Partnership) warns that efforts to contain Malaria may be jeopardized by the Ebola crisis.

In 2012, malaria killed 7,000 in Sierra Leone, Liberia and Guinea, and while these countries have since reached key malaria control targets, the necessary dedication of health resources to Ebola risks reversing malaria gains.

One key problem is that the early symptoms of Ebola and malaria are very similar. “According to Nafo, “at the moment when people have fevers, they are often afraid to go to healthcare facilities because they want to avoid being held in the Ebola treatment centers.” In Monrovia, Doctors Without Borders (MSF) is distributing antimalarial medicines to both prevent and treat new malaria cases and to minimize the number of people with malaria at Ebola treatment centers. Read Nafo’s full statement here.

Visit GBCHealth’s Ebola Outbreak Update page for more on the current epidemic, and contact us if you are interested in learning how your company can manage malaria in the face of the Ebola Outbreak.

Malaria: A Child Survival Story and the Quest for Greater Effectiveness

By Leith Greenslade (Vice-Chair, Child Health, MDG Health Alliance)

We are in the midst of a maternal and child survival revolution. In the last 25 years, the number of children who die before turning five has halved—from over 12 million to just over 6 million—as has the number of women and girls dying of pregnancy related causes. For the first time in humanity’s history we can contemplate a world in which preventable maternal and child deaths are close to zero.

The fight against malaria has contributed significantly to the decline in child deaths. The World Malaria Report in 2013 found that between 2000 and 2010 three million fewer children died from malaria. Success in controlling malaria means that the problem is becoming more concentrated in specific countries. The vast majority of child malaria deaths now occur in a handful of countries in sub-Saharan Africa. Just two countries—Nigeria and the Democratic Republic of Congo—account for a massive 40 percent of the burden.

Integrating maternal and child health interventions with malaria interventions is imperative because increased coverage of high impact maternal and child survival interventions leads to dramatic results; using existing health outreach platforms that deliver interventions straight to the consumer increases the probablity that those in greatest need will receive care; it is cost-effective; and it delivers increased patient value.

Continue reading the full article here.

The Global Fund’s New Funding Model and Malaria: Your Questions Answered

Launched in March 2014, the Global Fund’s new approach to grant-making offers recipient countries greater predictability and flexibility. During the 2014-2016 allocation period, the Global Fund will allocate USD 16.38 billion to the fight against the three diseases (read more about the allocations here).

So, how does the new funding model (NFM) impact funding for malaria? What types of funding can countries access for their malaria programs? What can RBM and the private sector do to ensure malaria is adequately funded?

Whitney White, Focal Point for the Private Sector Delegation to the Global Fund answers these questions and more here.


Sumitomo Chemical Announces Breakthrough in the Development of a New Mode of Action Insecticide

Only four classes of insecticide are currently recommended by the World Health Organization Pesticide Evaluation Scheme (WHOPES) for indoor residual spraying (IRS), with no new classes of insecticide for adult mosquito control having been introduced in the past forty years. With widespread and growing resistance to many of these compounds, malaria control programs have had very limited control options.

In a major development, Sumitomo Chemical has announced the recent submission to WHOPES of a new mode of action insecticide product for application in IRS programs. As this product has a different mode of action chemistry from currently available interventions, it is ideally suited for use in resistant management strategies and will help preserve the effectiveness of existing vector control tools. It is anticipated that this product will help combat the growing threat of insecticide resistance and will complement currently available vector control tools.

Read the full release here.

ExxonMobil’s Contribution to the Fight Against Malaria

Leveraging core competencies and taking advantage of the collective impact of partnerships

ExxonMobil’s response began as a workplace program and has evolved into a fully integrated signature community investment initiative, helping to mitigate effects of malaria on their business while helping countries and communities to meet malaria control targets.

In addition to donating more than USD 120 million since 2000, ExxonMobil applies their business competencies to the fight against malaria, including in the areas of portfolio management, supply chain consulting on net distribution and providing governance and management assistance to NGOs.

Following a clear set of indicators and plan to reduce child mortality and improve maternal health in Nigeria, ExxonMobil has embarked on numerous partnerships including with the Family Care Association on the Nigeria Malaria Control and preventive program, NMCPP to provide free LLINs, training for health workers and free RDTs, targeting families, pregnant women and children under-5 in seven states. Together, ExxonMobil and partner programs have reached almost 105 million people, provided 13 million nets, 2 million treatments, 1.1 million RDTs and trained more than 335,000 health care workers.

Sanofi and PATH Announce the First Antimalarial Treatments Produces with Semi-Synthetic Artemisinin

First shipment marks a critical step in improving access to treatment worldwide

Sanofi and PATH announced the delivery of the first large-scale batches of antimalarial treatments manufactured with a new semisynthetic artemisinin derivative to malaria-endemic countries in Africa including the Democratic Republic of Congo, Liberia and Nigeria.

The supply of artemisinin, a key ingredient in artemisinin-based combination therapies (ACTs) derived from the sweet wormwood plant, is volatile due to a number of factors, leading to inconsistent price and periodic shortages. The commercial production of semisynthetic artemisinin will strengthen the artemisinin supply chain, stabilize pricing and ensure greater availability of treatment.

Steve Davis, President and CEO of PATH, stated, “Semisynthetic artemisinin demonstrates how public-private partnerships, tenacity and an urgent and shared goal—saving children’s lives—can drive promising innovations to transformative global scale.”


CAMA Members’ Teleconference

Call for Private Sector Case Studies

Global Health Corps Fellowships Open at GBCHealth

Global Fund Private Sector Delgation Accepting Board Nominations

Support Seasonal Malaria Chemoprevention and Nutrition in Nigeria

Isaiah Owolabi Joins GBCHealth

World Malaria Report 2014 Highlights

Fighting Malaria Alongside Ebola

The Quest for Greater Effectiveness

The Global Fund’s New Funding Model and Malaria

Sumitomo Chemical Announces Development Breakthrough

ExxonMobil’s Contribution to the Fight

PATH and Sanofi Annouce First Semi-Synthetic Artemisinin Treatments


February 3

CAMA Member Q1 Teleconference

March 16-18

SPE E&P Health, Safety, Security and Environmental Conference

Denver, Colorado

March 31-April 1

33rd Global Fund Board Meeting

Geneva, Switzerland

April 25

World Malaria Day

May 13-15

28th RBM Partnership Board Meeting

Geneva, Switzerland

May 18-22

Global Malaria Technical Strategy Launches at World Health Assembly

Basel, Switzerland


Q2 CAMA Members Teleconference

June 1-5

SPE Forum: The Role of the Oil and Gas Industry in Community Health

Miami, Florida


CAMA State Level Partnership Workshop



Expands Efforts to Reduce Burden of Malaria in Africa

Donates N10M to UNICEF

Increases Support for Niger Delta Partnership Initiative

Launches New Corporate Malaria Management Program

Joins Ebola Response Efforts with Grant to CDC Foundation


27 November 2014
MMV Announces Collaborations with Cipla and Strides to Advance Life-Saving Treatment for Severe Malaria

02 November 2014
Gates Foundation Increases Commitment to Tackle Infectious Disease in Developing Countries

22 September 2014
UCSF, Google Earth Making Maps to Predict Malaria

21 September 2014
UN Special Envoy for Health Financing in Conversation with the Man on the Front Line of the Ebola Crisis

18 September 2014
Strengthening Public Health Pesticide Management in Coutnries Endemic with Malaria

15 August 2014
Special Envoy Applauds Historic Net Delivery in First Half of 2014

24 July 2014
GlaxoSmithKline Files it Entry in Race for a Malaria Vaccine


Malaria Elimination and the 2030 Sustainable Development Goals

To have the effectiveness of the MDGs in saving lives and controlling Malaria, UCSF Global Health Sciences argues for the need to make SDGl 3 specific and measurable.

The Contribution of Malaria Control to Maternal and Newborn Health

The latest in RBM’s Progress & Impact Series notes the profound impact that malaria control interventions have had on maternal and newborn health—averting an estimated 94,000 newborn deaths.

Malaria Investments: Corporate Social Responsibility at the National Level

Professor William Brieger, (JHPIEGO) provides details on how the private sector is truly starting to take on some of the burden of disease control.


Switching Poles (Institute of Tropical Medicine in Antwerp)

Africa Cup of Nations (United Against Malaria)

Community Engagement is Key to Malaria Prevention (Africa AIRS)

Eradicating Malaria is Critical to Healthier, More Productive Future (Joy Phumaphi, ALMA)

U-Report Nigeria: Advocating for Better Services Through SMS (UNICEF)

Corporate Alliance on Malaria in Africa Members and Representatives

Chair: Ernesto De La Torre, Global Public Health Coordinator, Chevron
Co-Chair: Dr. Gerhard Hesse, Head of Global Partnering/Vector Control, Bayer S.A.S.

Current Alliance Members















The Corporate Alliance on Malaria in Africa (CAMA) is a unique coalition of companies from various industries, all with business interests in Africa. Launched by Marathon Oil in 2006 and with GBCHealth as implementing partner and Secretariat, CAMA brings the collective force and voice of the private sector to drive impact on malaria in Africa from control to elimination.

For more information on how your company or organization can get involved, please contact Isaiah Owolabi at